bioTCI: biomolecular Targeted Covalent Inhibitor as a forefront drug platform (IMAGE)

The University of Electro-Communications

bioTCI: biomolecular Targeted Covalent Inhibitor as a forefront drug platform

Caption

(A) Major difference between bio TCI (lower) vs. conventional TCI (upper). (B) Our achievements on bio TCI research.

Credit

None

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.